| Mario | One moment, please <a href=" http://lynnefreeman.net/ervaring-met-dapoxetine.pdf ">dapoxetine farmasi</a> Now approved to treat liver and kidney cancer, Nexavar brought in €792 million last year, about $900 million. Its sales for the first half of this year amounted to €373 million, a bit less than the same period last year. So, new uses are key for continued growth. The thyroid cancer approval would be a help, but Bayer and Onyx had really hoped for a new indication in lung cancer, the third most common type of cancer in the U.S. That study fell short last year. |
|